AGER and ovarian cancer: A substantial link has been shown between high RAGE expression levels and unfavorable clinicopathological parameters such as the tumor size, the depth of stromal invasion, lymphovascular invasion, and the tumor stage, indicating that RAGE plays an important role in the course of ovarian cancer [114].